We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies.
- Authors
Dalisay, Doralyn S.; Tenebro, Chuckcris P.; Sabido, Edna M.; Suarez, Angelica Faith L.; Paderog, Melissa June V.; Reyes-Salarda, Rikka; Saludes, Jonel P.
- Abstract
Extensive research has been conducted on the isolation and study of bioactive compounds derived from marine sources. Several natural products have demonstrated potential as inducers of apoptosis and are currently under investigation in clinical trials. These marine-derived compounds selectively interact with extrinsic and intrinsic apoptotic pathways using a variety of molecular mechanisms, resulting in cell shrinkage, chromatin condensation, cytoplasmic blebs, apoptotic bodies, and phagocytosis by adjacent parenchymal cells, neoplastic cells, or macrophages. Numerous marine-derived compounds are currently undergoing rigorous examination for their potential application in cancer therapy. This review examines a total of 21 marine-derived compounds, along with their synthetic derivatives, sourced from marine organisms such as sponges, corals, tunicates, mollusks, ascidians, algae, cyanobacteria, fungi, and actinobacteria. These compounds are currently undergoing preclinical and clinical trials to evaluate their potential as apoptosis inducers for the treatment of different types of cancer. This review further examined the compound's properties and mode of action, preclinical investigations, clinical trial studies on single or combination therapy, and the prospective development of marine-derived anticancer therapies.
- Subjects
ACTINOBACTERIA; ANTINEOPLASTIC agents; CANCER treatment; APOPTOTIC bodies; SPONGES (Invertebrates); MARINE natural products
- Publication
Marine Drugs, 2024, Vol 22, Issue 3, p114
- ISSN
1660-3397
- Publication type
Article
- DOI
10.3390/md22030114